RICHARD EROYALRICHARD E ROYAL8960ROYAL, RICHARD EProfessorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson1400 Pressler StHouston77030-4008TXAuthorship 1676691Authorship 1686442Authorship 1696253Authorship 1727381Authorship 17442710Authorship 1798628Authorship 1866227Authorship 19187626Authorship 19293879166506Royal RE, Steinberg SM, Krouse RS, Heywood G, White DE, Hwu P, Marincola FM, Parkinson DR, Schwartzentruber DJ, Topalian SL, Yang JC, Rosenberg SAThe cancer journal from Scientific AmericanCorrelates of response to IL-2 therapy in patients treated for metastatic renal cancer and melanoma. Cancer J Sci Am. 1996 Mar-Apr; 2(2):91-8.Cancer J Sci Am1996-03-01T00:00:001996Correlates of response to IL-2 therapy in patients treated for metastatic renal cancer and melanoma.10770638Daly T, Royal RE, Kershaw MH, Treisman J, Wang G, Li W, Herlyn D, Eshhar Z, Hwu PCancer gene therapyRecognition of human colon cancer by T cells transduced with a chimeric receptor gene. Cancer Gene Ther. 2000 Feb; 7(2):284-91.Cancer Gene Ther2000-02-01T00:00:002000Recognition of human colon cancer by T cells transduced with a chimeric receptor gene.11928025Gannon CJ, Malone DL, Royal RE, Schreiber M, Bass BL, Napolitano LMSurgical endoscopyAdvanced proximal colon cancer. Surg Endosc. 2002 Mar; 16(3):446-9.Surg Endosc2001-11-16T00:00:002001Advanced proximal colon cancer.16087944Attia P, Phan GQ, Maker AV, Robinson MR, Quezado MM, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Restifo NP, Haworth LR, Levy C, Mavroukakis SA, Nichol G, Yellin MJ, Rosenberg SAJournal of clinical oncology : official journal of the American Society of Clinical OncologyAutoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. J Clin Oncol. 2005 Sep 01; 23(25):6043-53.J Clin Oncol2005-08-08T00:00:002005Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.18457330Klapper JA, Downey SG, Smith FO, Yang JC, Hughes MS, Kammula US, Sherry RM, Royal RE, Steinberg SM, Rosenberg SCancerHigh-dose interleukin-2 for the treatment of metastatic renal cell carcinoma : a retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006. Cancer. 2008 Jul 15; 113(2):293-301.Cancer2008-07-15T00:00:002008High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma : a retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006.21447969Citrin D, Camphausen K, Wood BJ, Quezado M, Denobile J, Pingpank JF, Royal RE, Alexander HR, Seidel G, Steinberg SM, Shuttack Y, Libutti SKOncologyA pilot feasibility study of TNFerade? biologic with capecitabine and radiation therapy followed by surgical resection for the treatment of rectal cancer. Oncology. 2010; 79(5-6):382-8.Oncology2011-03-25T00:00:002011A pilot feasibility study of TNFerade? biologic with capecitabine and radiation therapy followed by surgical resection for the treatment of rectal cancer.23032743Radvanyi LG, Bernatchez C, Zhang M, Fox PS, Miller P, Chacon J, Wu R, Lizee G, Mahoney S, Alvarado G, Glass M, Johnson VE, McMannis JD, Shpall E, Prieto V, Papadopoulos N, Kim K, Homsi J, Bedikian A, Hwu WJ, Patel S, Ross MI, Lee JE, Gershenwald JE, Lucci A, Royal R, Cormier JN, Davies MA, Mansaray R, Fulbright OJ, Toth C, Ramachandran R, Wardell S, Gonzalez A, Hwu PClinical cancer research : an official journal of the American Association for Cancer ResearchSpecific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients. Clin Cancer Res. 2012 Dec 15; 18(24):6758-70.Clin Cancer Res2012-10-02T00:00:002012Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients.24096759Rueth NM, Xing Y, Chiang YJ, Cromwell KD, Ross MI, Lee JE, Gershenwald JE, Royal RE, Cormier JNAnnals of surgeryIs surveillance imaging effective for detecting surgically treatable recurrences in patients with melanoma? A comparative analysis of stage-specific surveillance strategies. Ann Surg. 2014 Jun; 259(6):1215-22.Ann Surg2014-06-01T00:00:002014Is surveillance imaging effective for detecting surgically treatable recurrences in patients with melanoma? A comparative analysis of stage-specific surveillance strategies.GI Medical OncologyLeukemiaMelanoma Medical OncologySurgical OncologyMD AndersonPAUL FMANSFIELDPAUL F MANSFIELD8467MANSFIELD, PAUL FProfessorJAFFER AAJANIJAFFER A AJANI8473AJANI, JAFFER AProfessorHAGOP MKANTARJIANHAGOP M KANTARJIAN8501KANTARJIAN, HAGOP MProfessor2.188750.00247224416research areas2.559390.028187585coauthor of56.208213.421260similar to1195selected publicationsKEITH FRANCISFOURNIERKEITH FRANCIS FOURNIER9339FOURNIER, KEITH FRANCISAssociate ProfessorBRIAN DBADGWELLBRIAN D BADGWELL9276BADGWELL, BRIAN DAssociate ProfessorJANICE NICOLECORMIERJANICE NICOLE CORMIER8846CORMIER, JANICE NICOLEProfessorPATRICKHWUPATRICK HWU9108HWU, PATRICKProfessorMICHAEL JAMESOVERMANMICHAEL JAMES OVERMAN9176OVERMAN, MICHAEL JAMESAssociate ProfessorAuthorship 2168455Authorship 2217767Authorship 2225546Authorship 2225638Authorship 2229397Authorship 2243752Authorship 2257954Authorship 22585110Authorship 2260181Authorship 2271378Authorship 2282317Authorship 2298478Authorship 23008510Authorship 2302945Authorship 2306021Authorship 2315187Authorship 2336805Authorship 23393089334360Specht JM, Wang G, Do MT, Lam JS, Royal RE, Reeves ME, Rosenberg SA, Hwu PThe Journal of experimental medicineDendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases. J Exp Med. 1997 Oct 20; 186(8):1213-21.J Exp Med1997-10-20T00:00:001997Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases.16224277Blansfield JA, Beck KE, Tran K, Yang JC, Hughes MS, Kammula US, Royal RE, Topalian SL, Haworth LR, Levy C, Rosenberg SA, Sherry RMJournal of immunotherapy (Hagerstown, Md. : 1997)Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer. J Immunother. 2005 Nov-Dec; 28(6):593-8.J Immunother2005-11-01T00:00:002005Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer.16283570Maker AV, Phan GQ, Attia P, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Haworth LR, Levy C, Kleiner D, Mavroukakis SA, Yellin M, Rosenberg SAAnnals of surgical oncologyTumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study. Ann Surg Oncol. 2005 Dec; 12(12):1005-16.Ann Surg Oncol2005-10-21T00:00:002005Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study.16799341Maker AV, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Hughes M, Yellin MJ, Haworth LR, Levy C, Allen T, Mavroukakis SA, Attia P, Rosenberg SAJournal of immunotherapy (Hagerstown, Md. : 1997)Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma. J Immunother. 2006 Jul-Aug; 29(4):455-63.J Immunother2006-07-01T00:00:002006Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma.16946036Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, Royal RE, Topalian SL, Kammula US, Restifo NP, Zheng Z, Nahvi A, de Vries CR, Rogers-Freezer LJ, Mavroukakis SA, Rosenberg SAScience (New York, N.Y.)Cancer regression in patients after transfer of genetically engineered lymphocytes. Science. 2006 Oct 06; 314(5796):126-9.Science2006-08-31T00:00:002006Cancer regression in patients after transfer of genetically engineered lymphocytes.17942922Shimamura T, Royal RE, Kioi M, Nakajima A, Husain SR, Puri RKCancer researchInterleukin-4 cytotoxin therapy synergizes with gemcitabine in a mouse model of pancreatic ductal adenocarcinoma. Cancer Res. 2007 Oct 15; 67(20):9903-12.Cancer Res2007-10-15T00:00:002007Interleukin-4 cytotoxin therapy synergizes with gemcitabine in a mouse model of pancreatic ductal adenocarcinoma.18049334Yang JC, Hughes M, Kammula U, Royal R, Sherry RM, Topalian SL, Suri KB, Levy C, Allen T, Mavroukakis S, Lowy I, White DE, Rosenberg SAJournal of immunotherapy (Hagerstown, Md. : 1997)Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis. J Immunother. 2007 Nov-Dec; 30(8):825-30.J Immunother2007-11-01T00:00:002007Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis.18172279Blansfield JA, Caragacianu D, Alexander HR, Tangrea MA, Morita SY, Lorang D, Schafer P, Muller G, Stirling D, Royal RE, Libutti SKClinical cancer research : an official journal of the American Association for Cancer ResearchCombining agents that target the tumor microenvironment improves the efficacy of anticancer therapy. Clin Cancer Res. 2008 Jan 01; 14(1):270-80.Clin Cancer Res2008-01-01T00:00:002008Combining agents that target the tumor microenvironment improves the efficacy of anticancer therapy.18396204Royal RE, Pingpank JFSeminars in oncologyDiagnosis and management of peritoneal carcinomatosis arising from adenocarcinoma of the colon and rectum. Semin Oncol. 2008 Apr; 35(2):183-91.Semin Oncol2008-04-01T00:00:002008Diagnosis and management of peritoneal carcinomatosis arising from adenocarcinoma of the colon and rectum.19451549Johnson LA, Morgan RA, Dudley ME, Cassard L, Yang JC, Hughes MS, Kammula US, Royal RE, Sherry RM, Wunderlich JR, Lee CC, Restifo NP, Schwarz SL, Cogdill AP, Bishop RJ, Kim H, Brewer CC, Rudy SF, VanWaes C, Davis JL, Mathur A, Ripley RT, Nathan DA, Laurencot CM, Rosenberg SABloodGene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood. 2009 Jul 16; 114(3):535-46.Blood2009-05-18T00:00:002009Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.20336388Chang SB, Askew RL, Xing Y, Weaver S, Gershenwald JE, Lee JE, Royal R, Lucci A, Ross MI, Cormier JNAnnals of surgical oncologyProspective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients. Ann Surg Oncol. 2010 Oct; 17(10):2764-72.Ann Surg Oncol2010-03-25T00:00:002010Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients.20842054Royal RE, Levy C, Turner K, Mathur A, Hughes M, Kammula US, Sherry RM, Topalian SL, Yang JC, Lowy I, Rosenberg SAJournal of immunotherapy (Hagerstown, Md. : 1997)Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma. J Immunother. 2010 Oct; 33(8):828-33.J Immunother2010-10-01T00:00:002010Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma.21301973Ripley RT, Kemp CD, Davis JL, Langan RC, Royal RE, Libutti SK, Steinberg SM, Wood BJ, Kammula US, Fojo T, Avital IAnnals of surgical oncologyLiver resection and ablation for metastatic adrenocortical carcinoma. Ann Surg Oncol. 2011 Jul; 18(7):1972-9.Ann Surg Oncol2011-02-08T00:00:002011Liver resection and ablation for metastatic adrenocortical carcinoma.21343562Beasley GM, Riboh JC, Augustine CK, Zager JS, Hochwald SN, Grobmyer SR, Peterson B, Royal R, Ross MI, Tyler DSJournal of clinical oncology : official journal of the American Society of Clinical OncologyProspective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma. J Clin Oncol. 2011 Mar 20; 29(9):1210-5.J Clin Oncol2011-02-22T00:00:002011Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma.21653683Lieu CH, Lambert LA, Wolff RA, Eng C, Zhang N, Wen S, Rafeeq S, Taggart M, Fournier K, Royal R, Mansfield P, Overman MJAnnals of oncology : official journal of the European Society for Medical OncologySystemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix. Ann Oncol. 2012 Mar; 23(3):652-658.Ann Oncol2011-06-08T00:00:002011Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix.23020527Bilen MA, Taggart MW, Fournier K, Ellis LM, Mansfield PF, Eng C, Royal RE, Overman MJActa oncologica (Stockholm, Sweden)Pathologic complete response in poorly differentiated adenocarcinomas of the appendix: a case series. Acta Oncol. 2013 Jun; 52(5):1044-6.Acta Oncol2012-10-01T00:00:002012Pathologic complete response in poorly differentiated adenocarcinomas of the appendix: a case series.23648460Taggart MW, Galbincea J, Mansfield PF, Fournier KF, Royal RE, Overman MJ, Rashid A, Abraham SCThe American journal of surgical pathologyHigh-level microsatellite instability in appendiceal carcinomas. Am J Surg Pathol. 2013 Aug; 37(8):1192-200.Am J Surg Pathol2013-08-01T00:00:002013High-level microsatellite instability in appendiceal carcinomas.24149137Raghav KP, Shetty AV, Kazmi SM, Zhang N, Morris J, Taggart M, Fournier K, Royal R, Mansfield P, Eng C, Wolff RA, Overman MJThe oncologistImpact of molecular alterations and targeted therapy in appendiceal adenocarcinomas. Oncologist. 2013; 18(12):1270-7.Oncologist2013-10-22T00:00:002013Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomas.Authorship 2397382Authorship 2407063Authorship 2464007Authorship 2479576Authorship 2506465Authorship 2513575Authorship 2516686Authorship 2521586Authorship 2522594Authorship 2547827Authorship 2587735Authorship 2592465Authorship 2605249Authorship 26254128215641Ziegler MM, Royal RE, Brandt J, Drasnin J, Martin LWAnnals of surgeryExtended myectomy-myotomy. A therapeutic alternative for total intestinal aganglionosis. Ann Surg. 1993 Oct; 218(4):504-9; discussion 509-11.Ann Surg1993-10-01T00:00:001993Extended myectomy-myotomy. A therapeutic alternative for total intestinal aganglionosis.8971174Reeves ME, Royal RE, Lam JS, Rosenberg SA, Hwu PCancer researchRetroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res. 1996 Dec 15; 56(24):5672-7.Cancer Res1996-12-15T00:00:001996Retroviral transduction of human dendritic cells with a tumor-associated antigen gene.9461189Wang G, Chopra RK, Royal RE, Yang JC, Rosenberg SA, Hwu PNature medicineA T cell-independent antitumor response in mice with bone marrow cells retrovirally transduced with an antibody/Fc-gamma chain chimeric receptor gene recognizing a human ovarian cancer antigen. Nat Med. 1998 Feb; 4(2):168-72.Nat Med1998-02-01T00:00:001998A T cell-independent antitumor response in mice with bone marrow cells retrovirally transduced with an antibody/Fc-gamma chain chimeric receptor gene recognizing a human ovarian cancer antigen.15800326Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, Restifo NP, Royal RE, Kammula U, White DE, Mavroukakis SA, Rogers LJ, Gracia GJ, Jones SA, Mangiameli DP, Pelletier MM, Gea-Banacloche J, Robinson MR, Berman DM, Filie AC, Abati A, Rosenberg SAJournal of clinical oncology : official journal of the American Society of Clinical OncologyAdoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol. 2005 Apr 01; 23(10):2346-57.J Clin Oncol2005-04-01T00:00:002005Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.16531823Rosenberg SA, Sherry RM, Morton KE, Yang JC, Topalian SL, Royal RE, Kammula US, Restifo NP, Hughes MS, Schwarz SL, Ngo LT, Mavroukakis SA, White DEJournal of immunotherapy (Hagerstown, Md. : 1997)Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccines. J Immunother. 2006 Mar-Apr; 29(2):224-31.J Immunother2006-03-01T00:00:002006Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccines.17374707Khosravi A, Cutler CM, Kelly MH, Chang R, Royal RE, Sherry RM, Wodajo FM, Fedarko NS, Collins MTThe Journal of clinical endocrinology and metabolismDetermination of the elimination half-life of fibroblast growth factor-23. J Clin Endocrinol Metab. 2007 Jun; 92(6):2374-7.J Clin Endocrinol Metab2007-03-20T00:00:002007Determination of the elimination half-life of fibroblast growth factor-23.17982122Downey SG, Klapper JA, Smith FO, Yang JC, Sherry RM, Royal RE, Kammula US, Hughes MS, Allen TE, Levy CL, Yellin M, Nichol G, White DE, Steinberg SM, Rosenberg SAClinical cancer research : an official journal of the American Association for Cancer ResearchPrognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade. Clin Cancer Res. 2007 Nov 15; 13(22 Pt 1):6681-8.Clin Cancer Res2007-11-02T00:00:002007Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade.18765555Smith FO, Downey SG, Klapper JA, Yang JC, Sherry RM, Royal RE, Kammula US, Hughes MS, Restifo NP, Levy CL, White DE, Steinberg SM, Rosenberg SAClinical cancer research : an official journal of the American Association for Cancer ResearchTreatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccines. Clin Cancer Res. 2008 Sep 01; 14(17):5610-8.Clin Cancer Res2008-09-01T00:00:002008Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccines.18809613Dudley ME, Yang JC, Sherry R, Hughes MS, Royal R, Kammula U, Robbins PF, Huang J, Citrin DE, Leitman SF, Wunderlich J, Restifo NP, Thomasian A, Downey SG, Smith FO, Klapper J, Morton K, Laurencot C, White DE, Rosenberg SAJournal of clinical oncology : official journal of the American Society of Clinical OncologyAdoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. J Clin Oncol. 2008 Nov 10; 26(32):5233-9.J Clin Oncol2008-09-22T00:00:002008Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens.19050961Miao N, Pingpank JF, Alexander HR, Royal R, Steinberg SM, Quezado MM, Beresnev T, Quezado ZMAnnals of surgical oncologyCytoreductive surgery and continuous hyperthermic peritoneal perfusion in patients with mesothelioma and peritoneal carcinomatosis: hemodynamic, metabolic, and anesthetic considerations. Ann Surg Oncol. 2009 Feb; 16(2):334-44.Ann Surg Oncol2008-12-03T00:00:002008Cytoreductive surgery and continuous hyperthermic peritoneal perfusion in patients with mesothelioma and peritoneal carcinomatosis: hemodynamic, metabolic, and anesthetic considerations.21081714Xing Y, Bronstein Y, Ross MI, Askew RL, Lee JE, Gershenwald JE, Royal R, Cormier JNJournal of the National Cancer InstituteContemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. J Natl Cancer Inst. 2011 Jan 19; 103(2):129-42.J Natl Cancer Inst2010-11-16T00:00:002010Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis.22914178Cromwell KD, Ross MI, Xing Y, Gershenwald JE, Royal RE, Lucci A, Lee JE, Cormier JNMelanoma researchVariability in melanoma post-treatment surveillance practices by country and physician specialty: a systematic review. Melanoma Res. 2012 Oct; 22(5):376-85.Melanoma Res2012-10-01T00:00:002012Variability in melanoma post-treatment surveillance practices by country and physician specialty: a systematic review.23489943Alexander HR, Bartlett DL, Pingpank JF, Libutti SK, Royal R, Hughes MS, Holtzman M, Hanna N, Turner K, Beresneva T, Zhu YSurgeryTreatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma. Surgery. 2013 Jun; 153(6):779-86.Surgery2013-03-13T00:00:002013Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma.23752305Hyngstrom JR, Chiang YJ, Cromwell KD, Ross MI, Xing Y, Mungovan KS, Lee JE, Gershenwald JE, Royal RE, Lucci A, Armer JM, Cormier JNMelanoma researchProspective assessment of lymphedema incidence and lymphedema-associated symptoms following lymph node surgery for melanoma. Melanoma Res. 2013 Aug; 23(4):290-7.Melanoma Res2013-08-01T00:00:002013Prospective assessment of lymphedema incidence and lymphedema-associated symptoms following lymph node surgery for melanoma.Authorship 2655001Authorship 2677017Authorship 2681516Authorship 2698499Authorship 2702056Authorship 2713033612140736Royal RE, Kershaw MH, Reeves ME, Wang G, Daly T, Treisman J, Lam J, Hwu PGene therapyIncreased functional expression of transgene in primary human lymphocytes using retroviral vectors modified with IRES and splicing motifs. Gene Ther. 2002 Aug; 9(16):1085-92.Gene Ther2002-08-01T00:00:002002Increased functional expression of transgene in primary human lymphocytes using retroviral vectors modified with IRES and splicing motifs.16237114Rosenberg SA, Sherry RM, Morton KE, Scharfman WJ, Yang JC, Topalian SL, Royal RE, Kammula U, Restifo NP, Hughes MS, Schwartzentruber D, Berman DM, Schwarz SL, Ngo LT, Mavroukakis SA, White DE, Steinberg SMJournal of immunology (Baltimore, Md. : 1950)Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma. J Immunol. 2005 Nov 01; 175(9):6169-76.J Immunol2005-11-01T00:00:002005Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma.16710025Beck KE, Blansfield JA, Tran KQ, Feldman AL, Hughes MS, Royal RE, Kammula US, Topalian SL, Sherry RM, Kleiner D, Quezado M, Lowy I, Yellin M, Rosenberg SA, Yang JCJournal of clinical oncology : official journal of the American Society of Clinical OncologyEnterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J Clin Oncol. 2006 May 20; 24(15):2283-9.J Clin Oncol2006-05-20T00:00:002006Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4.19777192Ripley RT, Davis JL, Klapper JA, Mathur A, Kammula U, Royal RE, Yang JC, Sherry RM, Hughes MS, Libutti SK, White DE, Steinberg SM, Dudley ME, Rosenberg SA, Avital IAnnals of surgical oncologyLiver resection for metastatic melanoma with postoperative tumor-infiltrating lymphocyte therapy. Ann Surg Oncol. 2010 Jan; 17(1):163-70.Ann Surg Oncol2009-09-24T00:00:002009Liver resection for metastatic melanoma with postoperative tumor-infiltrating lymphocyte therapy.20734041Frankel TL, Burns W, Riley J, Morgan RA, Davis JL, Hanada K, Quezado M, Rosenberg SA, Royal RECancer immunology, immunotherapy : CIIIdentification and characterization of a tumor infiltrating CD56(+)/CD16 (-) NK cell subset with specificity for pancreatic and prostate cancer cell lines. Cancer Immunol Immunother. 2010 Dec; 59(12):1757-69.Cancer Immunol Immunother2010-08-24T00:00:002010Identification and characterization of a tumor infiltrating CD56(+)/CD16 (-) NK cell subset with specificity for pancreatic and prostate cancer cell lines.23793364Turaga K, Levine E, Barone R, Sticca R, Petrelli N, Lambert L, Nash G, Morse M, Adbel-Misih R, Alexander HR, Attiyeh F, Bartlett D, Bastidas A, Blazer T, Chu Q, Chung K, Dominguez-Parra L, Espat NJ, Foster J, Fournier K, Garcia R, Goodman M, Hanna N, Harrison L, Hoefer R, Holtzman M, Kane J, Labow D, Li B, Lowy A, Mansfield P, Ong E, Pameijer C, Pingpank J, Quinones M, Royal R, Salti G, Sardi A, Shen P, Skitzki J, Spellman J, Stewart J, Esquivel JAnnals of surgical oncologyConsensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States. Ann Surg Oncol. 2014 May; 21(5):1501-5.Ann Surg Oncol2013-06-21T00:00:002013Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States.Authorship 2736106Authorship 27472312Authorship 2748147Authorship 2749376Authorship 27668728680655Krouse RS, Royal RE, Heywood G, Weintraub BD, White DE, Steinberg SM, Rosenberg SA, Schwartzentruber DJJournal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological TherapyThyroid dysfunction in 281 patients with metastatic melanoma or renal carcinoma treated with interleukin-2 alone. J Immunother Emphasis Tumor Immunol. 1995 Nov; 18(4):272-8.J Immunother Emphasis Tumor Immunol1995-11-01T00:00:001995Thyroid dysfunction in 281 patients with metastatic melanoma or renal carcinoma treated with interleukin-2 alone.19434456Alexander HR, Bartlett DL, Libutti SK, Pingpank JF, Fraker DL, Royal R, Steinberg SM, Helsabeck CB, Beresneva THAnnals of surgical oncologyAnalysis of factors associated with outcome in patients undergoing isolated hepatic perfusion for unresectable liver metastases from colorectal center. Ann Surg Oncol. 2009 Jul; 16(7):1852-9.Ann Surg Oncol2009-05-12T00:00:002009Analysis of factors associated with outcome in patients undergoing isolated hepatic perfusion for unresectable liver metastases from colorectal center.23001080Overman MJ, Fournier K, Hu CY, Eng C, Taggart M, Royal R, Mansfield P, Chang GJAnnals of surgeryImproving the AJCC/TNM staging for adenocarcinomas of the appendix: the prognostic impact of histological grade. Ann Surg. 2013 Jun; 257(6):1072-8.Ann Surg2013-06-01T00:00:002013Improving the AJCC/TNM staging for adenocarcinomas of the appendix: the prognostic impact of histological grade.23233234Schaub NP, Alimchandani M, Quezado M, Kalina P, Eberhardt JS, Hughes MS, Beresnev T, Hassan R, Bartlett DL, Libutti SK, Pingpank JF, Royal RE, Kammula US, Pandalai P, Phan GQ, Stojadinovic A, Rudloff U, Alexander HR, Avital IAnnals of surgical oncologyA novel nomogram for peritoneal mesothelioma predicts survival. Ann Surg Oncol. 2013 Feb; 20(2):555-61.Ann Surg Oncol2012-12-12T00:00:002012A novel nomogram for peritoneal mesothelioma predicts survival.23551693Matin SF, Cormier JN, Ward JF, Pisters LL, Wood CG, Dinney CP, Royal RE, Huang X, Pettaway CABJU internationalPhase 1 prospective evaluation of the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy in patients with penile carcinoma. BJU Int. 2013 Jun; 111(7):1068-74.BJU Int2013-04-02T00:00:002013Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy in patients with penile carcinoma.Authorship 2912498Authorship 2916368Authorship 2939044Authorship 2944742Authorship 2950828Authorship 2960288Authorship 2961519Authorship 299857725145500Beasley GM, Speicher P, Augustine CK, Dolber PC, Peterson BL, Sharma K, Mosca PJ, Royal R, Ross M, Zager JS, Tyler DSAnnals of surgical oncologyA multicenter phase I dose escalation trial to evaluate safety and tolerability of intra-arterial temozolomide for patients with advanced extremity melanoma using normothermic isolated limb infusion. Ann Surg Oncol. 2015 Jan; 22(1):287-94.Ann Surg Oncol2014-08-22T00:00:002014A multicenter phase I dose escalation trial to evaluate safety and tolerability of intra-arterial temozolomide for patients with advanced extremity melanoma using normothermic isolated limb infusion.25196740Fang S, Wang Y, Chun YS, Liu H, Ross MI, Gershenwald JE, Cormier JN, Royal RE, Lucci A, Schacherer CW, Reveille JD, Sui D, Bassett RL, Wang LE, Wei Q, Amos CI, Lee JEInternational journal of cancerThe relationship between blood IL-12p40 level and melanoma progression. Int J Cancer. 2015 Apr 15; 136(8):1874-80.Int J Cancer2014-09-18T00:00:002014The relationship between blood IL-12p40 level and melanoma progression.25582740Choe JH, Overman MJ, Fournier KF, Royal RE, Ohinata A, Rafeeq S, Beaty K, Phillips JK, Wolff RA, Mansfield PF, Eng CAnnals of surgical oncologyImproved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms. Ann Surg Oncol. 2015 Aug; 22(8):2578-84.Ann Surg Oncol2015-01-13T00:00:002015Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms.25698402Dineen SP, Royal RE, Hughes MS, Sagebiel T, Bhosale P, Overman M, Matamoros A, Mansfield PF, Fournier KFAnnals of surgical oncologyA Simplified Preoperative Assessment Predicts Complete Cytoreduction and Outcomes in Patients with Low-Grade Mucinous Adenocarcinoma of the Appendix. Ann Surg Oncol. 2015 Oct; 22(11):3640-6.Ann Surg Oncol2015-02-20T00:00:002015A Simplified Preoperative Assessment Predicts Complete Cytoreduction and Outcomes in Patients with Low-Grade Mucinous Adenocarcinoma of the Appendix.25779565Fang S, Wang Y, Sui D, Liu H, Ross MI, Gershenwald JE, Cormier JN, Royal RE, Lucci A, Schacherer CW, Gardner JM, Reveille JD, Bassett RL, Wang LE, Wei Q, Amos CI, Lee JEJournal of clinical oncology : official journal of the American Society of Clinical OncologyC-reactive protein as a marker of melanoma progression. J Clin Oncol. 2015 Apr 20; 33(12):1389-96.J Clin Oncol2015-03-16T00:00:002015C-reactive protein as a marker of melanoma progression.25809989Cromwell KD, Chiang YJ, Armer J, Heppner PP, Mungovan K, Ross MI, Gershenwald JE, Lee JE, Royal RE, Lucci A, Cormier JNEuropean journal of cancer careIs surviving enough? Coping and impact on activities of daily living among melanoma patients with lymphoedema. Eur J Cancer Care (Engl). 2015 Sep; 24(5):724-33.Eur J Cancer Care (Engl)2015-03-24T00:00:002015Is surviving enough? Coping and impact on activities of daily living among melanoma patients with lymphoedema.25848976Fang S, Wang Y, Chun YS, Liu H, Ross MI, Gershenwald JE, Cormier JN, Royal RE, Lucci A, Schacherer CW, Reveille JD, Chen W, Sui D, Bassett RL, Wang LE, Wei Q, Amos CI, Lee JEThe Journal of investigative dermatologyAssociation of Common Genetic Polymorphisms with Melanoma Patient IL-12p40 Blood Levels, Risk, and Outcomes. J Invest Dermatol. 2015 Sep; 135(9):2266-2272.J Invest Dermatol2015-04-07T00:00:002015Association of Common Genetic Polymorphisms with Melanoma Patient IL-12p40 Blood Levels, Risk, and Outcomes.26342838Dineen SP, Robinson KA, Roland CL, Beaty KA, Rafeeq S, Mansfield PF, Royal RE, Fournier KFThe Journal of surgical researchFeeding tube placement during cytoreductive surgery and heated intraperitoneal chemotherapy does not improve postoperative nutrition and is associated with longer length of stay and higher readmission rates. J Surg Res. 2016 Jan; 200(1):158-63.J Surg Res2015-08-13T00:00:002015Feeding tube placement during cytoreductive surgery and heated intraperitoneal chemotherapy does not improve postoperative nutrition and is associated with longer length of stay and higher readmission rates.74Professor14Associate Professor12490843Royal RE, Delpassand ES, Shapiro SE, Fritsche HA, Vassilopoulou-Sellin R, Sherman SI, Gagel RF, Evans DB, Lee JESurgeryImproving the yield of preoperative parathyroid localization: technetium Tc 99m-sestamibi imaging after thyroid suppression. Surgery. 2002 Dec; 132(6):968-74; discussion 974-5.Surgery2002-12-01T00:00:002002Improving the yield of preoperative parathyroid localization: technetium Tc 99m-sestamibi imaging after thyroid suppression.Authorship 841667Authorship 846944Authorship 848485Authorship 848656Authorship 850934Authorship 852734Authorship 862819Authorship 863483Annals of Surgical OncologyA Simplified Preoperative Assessment Predicts Complete Cytoreduction and Outcomes in Patients with Low-Grade Mucinous Adenocarcinoma of the Appendix. Annals of Surgical Oncology. 22:3640-3646.A Simplified Preoperative Assessment Predicts Complete Cytoreduction and Outcomes in Patients with Low-Grade Mucinous Adenocarcinoma of the AppendixJournal of Clinical OncologyAssociation of Vitamin D levels with outcome in patients with melanoma after adjustment for C-reactive protein. Journal of Clinical Oncology. 34:1741-1747.Association of Vitamin D levels with outcome in patients with melanoma after adjustment for C-reactive proteinAnnals of Surgical OncologyResults of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases. Annals of Surgical Oncology. 1-11.Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver MetastasesAnnals of Surgical OncologyIntrathoracic Chemoperfusion Decreases Recurrences in Patients with Full-Thickness Diaphragm Involvement with Mucinous Appendiceal Adenocarcinoma. Annals of Surgical Oncology. 1-6.Intrathoracic Chemoperfusion Decreases Recurrences in Patients with Full-Thickness Diaphragm Involvement with Mucinous Appendiceal AdenocarcinomaAnnals of Surgical OncologyLow-grade Appendiceal Mucinous Neoplasm of Uncertain Malignant Potential (LAMN-UMP). Annals of Surgical Oncology. 1-7.Low-grade Appendiceal Mucinous Neoplasm of Uncertain Malignant Potential (LAMN-UMP)European Journal of Cancer CareIs surviving enough? Coping and impact on activities of daily living among melanoma patients with lymphoedema. European Journal of Cancer Care. 24:724-733.Is surviving enough? Coping and impact on activities of daily living among melanoma patients with lymphoedemaJournal of Investigative DermatologyAssociation of Common Genetic Polymorphisms with Melanoma Patient IL-12p40 Blood Levels, Risk, and Outcomes. Journal of Investigative Dermatology. Association of Common Genetic Polymorphisms with Melanoma Patient IL-12p40 Blood Levels, Risk, and OutcomesActa OncologicaPathologic complete response in poorly differentiated adenocarcinomas of the appendix. Acta Oncologica. 52:1046-1048.Pathologic complete response in poorly differentiated adenocarcinomas of the appendix27001565Fang S, Sui D, Wang Y, Liu H, Chiang YJ, Ross MI, Gershenwald JE, Cormier JN, Royal RE, Lucci A, Wargo J, Hu MI, Gardner JM, Reveille JD, Bassett RL, Wei Q, Amos CI, Lee JEJournal of clinical oncology : official journal of the American Society of Clinical OncologyAssociation of Vitamin D Levels With Outcome in Patients With Melanoma After Adjustment For C-Reactive Protein. J Clin Oncol. 2016 05 20; 34(15):1741-7.J Clin Oncol2016-03-21T00:00:002016Association of Vitamin D Levels With Outcome in Patients With Melanoma After Adjustment For C-Reactive Protein.Authorship 8875209D006979Procedures1545040.691319Hyperthermia, InducedD001063Disorders672320.803679Appendiceal NeoplasmsAuthorship 9039155Authorship 9110503Authorship 91137911Authorship 9137497Authorship 9139788Authorship 9141025Authorship 9143852Authorship 9186872Authorship 92030811Authorship 9219107Authorship 92355610Authorship 92508337Authorship 9271976Authorship 9278856Authorship 93006129Authorship 93068713Authorship 93071213Authorship 9317661326597368Hughes MS, Zager J, Faries M, Alexander HR, Royal RE, Wood B, Choi J, McCluskey K, Whitman E, Agarwala S, Siskin G, Nutting C, Toomey MA, Webb C, Beresnev T, Pingpank JFAnnals of surgical oncologyResults of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases. Ann Surg Oncol. 2016 Apr; 23(4):1309-19.Ann Surg Oncol2015-11-23T00:00:002015Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases.27027310Grotz TE, Mansfield PF, Royal RE, Mann GN, Rafeeq S, Beaty KA, Overman MJ, Fournier KFAnnals of surgical oncologyIntrathoracic Chemoperfusion Decreases Recurrences in Patients with Full-Thickness Diaphragm Involvement with Mucinous Appendiceal Adenocarcinoma. Ann Surg Oncol. 2016 09; 23(9):2914-9.Ann Surg Oncol2016-03-30T00:00:002016Intrathoracic Chemoperfusion Decreases Recurrences in Patients with Full-Thickness Diaphragm Involvement with Mucinous Appendiceal Adenocarcinoma.27660258Fournier K, Rafeeq S, Taggart M, Kanaby P, Ning J, Chen HC, Overman M, Raghav K, Eng C, Mansfield P, Royal RAnnals of surgical oncologyLow-grade Appendiceal Mucinous Neoplasm of Uncertain Malignant Potential (LAMN-UMP): Prognostic Factors and Implications for Treatment and Follow-up. Ann Surg Oncol. 2017 Jan; 24(1):187-193.Ann Surg Oncol2016-09-22T00:00:002016Low-grade Appendiceal Mucinous Neoplasm of Uncertain Malignant Potential (LAMN-UMP): Prognostic Factors and Implications for Treatment and Follow-up.28643069Badgwell B, Blum M, Das P, Estrella J, Wang X, Fournier K, Royal R, Mansfield P, Ajani JSurgical endoscopyLessons learned from a phase II clinical trial of laparoscopic HIPEC for gastric cancer. Surg Endosc. 2018 01; 32(1):512.Surg Endosc2017-06-22T00:00:002017Lessons learned from a phase II clinical trial of laparoscopic HIPEC for gastric cancer.28506255Uemura M, Qiao W, Fournier K, Morris J, Mansfield P, Eng C, Royal RE, Wolff RA, Raghav K, Mann GN, Overman MJBMC cancerRetrospective study of nonmucinous appendiceal adenocarcinomas: role of systemic chemotherapy and cytoreductive surgery. BMC Cancer. 2017 05 15; 17(1):331.BMC Cancer2017-05-15T00:00:002017Retrospective study of nonmucinous appendiceal adenocarcinomas: role of systemic chemotherapy and cytoreductive surgery.28799004Badgwell B, Blum M, Das P, Estrella J, Wang X, Ho L, Fournier K, Royal R, Mansfield P, Ajani JAnnals of surgical oncologyPhase II Trial of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Carcinomatosis or Positive Peritoneal Cytology in Patients with Gastric Adenocarcinoma. Ann Surg Oncol. 2017 Oct; 24(11):3338-3344.Ann Surg Oncol2017-08-10T00:00:002017Phase II Trial of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Carcinomatosis or Positive Peritoneal Cytology in Patients with Gastric Adenocarcinoma.29124485Dineen SP, Royal RE, Mansfield PF, Fournier KFAnnals of surgical oncologyComment on: External Validation of the Simplified Preoperative Assessment for Low-Grade Mucinous Adenocarcinoma of the Appendix. Ann Surg Oncol. 2017 12; 24(Suppl 3):627.Ann Surg Oncol2017-11-09T00:00:002017Comment on: External Validation of the Simplified Preoperative Assessment for Low-Grade Mucinous Adenocarcinoma of the Appendix.28979717Grotz TE, Royal RE, Mansfield PF, Overman MJ, Mann GN, Robinson KA, Beaty KA, Rafeeq S, Matamoros A, Taggart MW, Fournier KFWorld journal of gastrointestinal oncologyStratification of outcomes for mucinous appendiceal adenocarcinoma with peritoneal metastasis by histological grade. World J Gastrointest Oncol. 2017 Sep 15; 9(9):354-362.World J Gastrointest Oncol2017-09-15T00:00:002017Stratification of outcomes for mucinous appendiceal adenocarcinoma with peritoneal metastasis by histological grade.28831698Sagebiel TL, Mohamed A, Matamoros A, Taggart MW, Doamekpor F, Raghav KP, Mann GN, Mansfield PF, Eng C, Royal RE, Foo WC, Ensor JE, Fournier KF, Overman MJAnnals of surgical oncologyUtility of Appendiceal Calcifications Detected on Computed Tomography as a Predictor for an Underlying Appendiceal Epithelial Neoplasm. Ann Surg Oncol. 2017 Nov; 24(12):3667-3672.Ann Surg Oncol2017-08-22T00:00:002017Utility of Appendiceal Calcifications Detected on Computed Tomography as a Predictor for an Underlying Appendiceal Epithelial Neoplasm.28695394Grotz TE, Overman MJ, Eng C, Raghav KP, Royal RE, Mansfield PF, Mann GN, Robinson KA, Beaty KA, Rafeeq S, Matamoros A, Taggart MW, Fournier KFAnnals of surgical oncologyCytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient Selection. Ann Surg Oncol. 2017 Sep; 24(9):2646-2654.Ann Surg Oncol2017-07-10T00:00:002017Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient Selection.29193085Fisher SB, Rafeeq S, Hess K, Grotz TE, Mansfield P, Royal R, Badgwell B, Fleming J, Fournier K, Mann GNJournal of surgical oncologyElevated brain natriuretic peptide (BNP) is an early marker for patients at risk for complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS?+?HIPEC). J Surg Oncol. 2018 Mar; 117(4):685-691.J Surg Oncol2017-11-28T00:00:002017Elevated brain natriuretic peptide (BNP) is an early marker for patients at risk for complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS?+?HIPEC).29393964Ikoma N, Cormier JN, Feig B, Du XL, Yamal JM, Hofstetter W, Das P, Ajani JA, Roland CL, Fournier K, Royal R, Mansfield P, Badgwell BDCancerRacial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006-2014. Cancer. 2018 03 01; 124(5):998-1007.Cancer2018-02-02T00:00:002018Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006-2014.29746918Hall CS, Ross M, Bowman Bauldry JB, Upshaw J, Karhade MG, Royal R, Patel S, Lucci AJournal of the American College of SurgeonsCirculating Tumor Cells in Stage IV Melanoma Patients. J Am Coll Surg. 2018 07; 227(1):116-124.J Am Coll Surg2018-05-07T00:00:002018Circulating Tumor Cells in Stage IV Melanoma Patients.29848573Forget MA, Haymaker C, Hess KR, Meng YJ, Creasy C, Karpinets T, Fulbright OJ, Roszik J, Woodman SE, Kim YU, Sakellariou-Thompson D, Bhatta A, Wahl A, Flores E, Thorsen ST, Tavera RJ, Ramachandran R, Gonzalez AM, Toth CL, Wardell S, Mansaray R, Patel V, Carpio DJ, Vaughn C, Farinas CM, Velasquez PG, Hwu WJ, Patel SP, Davies MA, Diab A, Glitza IC, Tawbi H, Wong MK, Cain S, Ross MI, Lee JE, Gershenwald JE, Lucci A, Royal R, Cormier JN, Wargo JA, Radvanyi LG, Torres-Cabala CA, Beroukhim R, Hwu P, Amaria RN, Bernatchez CClinical cancer research : an official journal of the American Association for Cancer ResearchProspective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome. Clin Cancer Res. 2018 09 15; 24(18):4416-4428.Clin Cancer Res2018-05-30T00:00:002018Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome.29361468Amaria RN, Prieto PA, Tetzlaff MT, Reuben A, Andrews MC, Ross MI, Glitza IC, Cormier J, Hwu WJ, Tawbi HA, Patel SP, Lee JE, Gershenwald JE, Spencer CN, Gopalakrishnan V, Bassett R, Simpson L, Mouton R, Hudgens CW, Zhao L, Zhu H, Cooper ZA, Wani K, Lazar A, Hwu P, Diab A, Wong MK, McQuade JL, Royal R, Lucci A, Burton EM, Reddy S, Sharma P, Allison J, Futreal PA, Woodman SE, Davies MA, Wargo JAThe Lancet. OncologyNeoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial. Lancet Oncol. 2018 02; 19(2):181-193.Lancet Oncol2018-01-18T00:00:002018Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.30297909Amaria RN, Reddy SM, Tawbi HA, Davies MA, Ross MI, Glitza IC, Cormier JN, Lewis C, Hwu WJ, Hanna E, Diab A, Wong MK, Royal R, Gross N, Weber R, Lai SY, Ehlers R, Blando J, Milton DR, Woodman S, Kageyama R, Wells DK, Hwu P, Patel SP, Lucci A, Hessel A, Lee JE, Gershenwald J, Simpson L, Burton EM, Posada L, Haydu L, Wang L, Zhang S, Lazar AJ, Hudgens CW, Gopalakrishnan V, Reuben A, Andrews MC, Spencer CN, Prieto V, Sharma P, Allison J, Tetzlaff MT, Wargo JANature medicineNeoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med. 2018 11; 24(11):1649-1654.Nat Med2018-10-08T00:00:002018Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.30361510Amaria RN, Reddy SM, Tawbi HA, Davies MA, Ross MI, Glitza IC, Cormier JN, Lewis C, Hwu WJ, Hanna E, Diab A, Wong MK, Royal R, Gross N, Weber R, Lai SY, Ehlers R, Blando J, Milton DR, Woodman S, Kageyama R, Wells DK, Hwu P, Patel SP, Lucci A, Hessel A, Lee JE, Gershenwald J, Simpson L, Burton EM, Posada L, Haydu L, Wang L, Zhang S, Lazar AJ, Hudgens CW, Gopalakrishnan V, Reuben A, Andrews MC, Spencer CN, Prieto V, Sharma P, Allison J, Tetzlaff MT, Wargo JANature medicineAuthor Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med. 2018 Dec; 24(12):1941.Nat Med2018-12-01T00:00:002018Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.30361511Amaria RN, Reddy SM, Tawbi HA, Davies MA, Ross MI, Glitza IC, Cormier JN, Lewis C, Hwu WJ, Hanna E, Diab A, Wong MK, Royal R, Gross N, Weber R, Lai SY, Ehlers R, Blando J, Milton DR, Woodman S, Kageyama R, Wells DK, Hwu P, Patel SP, Lucci A, Hessel A, Lee JE, Gershenwald J, Simpson L, Burton EM, Posada L, Haydu L, Wang L, Zhang S, Lazar AJ, Hudgens CW, Gopalakrishnan V, Reuben A, Andrews MC, Spencer CN, Prieto V, Sharma P, Allison J, Tetzlaff MT, Wargo JANature medicinePublisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med. 2018 Dec; 24(12):1942.Nat Med2018-12-01T00:00:002018Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.D008545Disorders68053010.290119MelanomaD010534Disorders2638130.599216Peritoneal NeoplasmsD002288Disorders2054350.749863Adenocarcinoma, MucinousAuthorship 9533221131383963Nagarajan P, Piao J, Ning J, Noordenbos LE, Curry JL, Torres-Cabala CA, Diwan AH, Ivan D, Aung PP, Ross MI, Royal RE, Wargo JA, Wang WL, Samdani R, Lazar AJ, Rashid A, Davies MA, Prieto VG, Gershenwald JE, Tetzlaff MTModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncPrognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features. Mod Pathol. 2020 03; 33(3):496-513.Mod Pathol2019-08-05T00:00:002019Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features.Authorship 976492331983613Snyder RA, Fournier K, Royal R, Venook AP, Chang GJClinical colorectal cancerHeated Intraperitoneal Chemotherapy for Colorectal Carcinomatosis: Emerging Evidence. Clin Colorectal Cancer. 2020 03; 19(1):1-4.Clin Colorectal Cancer2020-01-02T00:00:002020Heated Intraperitoneal Chemotherapy for Colorectal Carcinomatosis: Emerging Evidence.Authorship 977351632015020Lucci A, Hall CS, Patel SP, Narendran B, Bauldry JB, Royal RE, Karhade M, Upshaw JR, Wargo JA, Glitza IC, Wong MKK, Amaria RN, Tawbi HA, Diab A, Davies MA, Gershenwald JE, Lee JE, Hwu P, Ross MIClinical cancer research : an official journal of the American Association for Cancer ResearchCirculating Tumor Cells and Early Relapse in Node-positive Melanoma. Clin Cancer Res. 2020 04 15; 26(8):1886-1895.Clin Cancer Res2020-02-03T00:00:002020Circulating Tumor Cells and Early Relapse in Node-positive Melanoma.Authorship 996641732769428Malpica A, Euscher ED, Marques-Piubelli ML, Ferrufino-Schmidt MC, Miranda RN, Sams R, Royal RE, Raghav KPS, Fournier KF, Ramalingam PThe American journal of surgical pathologyMalignant Mesothelioma of the Peritoneum in Women: A Clinicopathologic Study of 164 Cases. Am J Surg Pathol. 2021 01; 45(1):45-58.Am J Surg Pathol2021-01-01T00:00:002021Malignant Mesothelioma of the Peritoneum in Women: A Clinicopathologic Study of 164 Cases.Authorship 1025089934261675Raghav K, Liu S, Overman MJ, Willett AF, Knafl M, Fu SC, Malpica A, Prasad S, Royal RE, Scally CP, Mansfield PF, Wistuba II, Futreal AP, Maru DM, Solis Soto LM, Parra Cuentas ER, Chen H, Villalobos P, Verma A, Mahvash A, Hwu P, Cortazar P, McKenna E, Yun C, Dervin S, Schulze K, Darbonne WC, Morani AC, Kopetz S, Fournier KF, Woodman SE, Yao JC, Varadhachary GR, Halperin DMCancer discoveryEfficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma. Cancer Discov. 2021 11; 11(11):2738-2747.Cancer Discov2021-07-14T00:00:002021Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma.Authorship 10647111236853519Erstad DJ, Robinson KA, Beaty K, Rafeeq S, Chiang YJ, Raghav K, Shen JP, Overman MJ, Foo WC, Taggart MW, Mansfield PF, Royal RE, Fournier KF, Scally CPLangenbeck's archives of surgeryPrognostic significance of acellular mucin in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for appendiceal neoplasms. Langenbecks Arch Surg. 2023 Feb 28; 408(1):110.Langenbecks Arch Surg2023-02-28T00:00:002023Prognostic significance of acellular mucin in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for appendiceal neoplasms.Authorship 1078764837624514Bhutiani N, White MG, Kim BJ, Scally CP, Helmink BA, Mansfield PF, Fournier KF, Royal REAnnals of surgical oncologyDecreasing Environmental Operating Room Chemotherapy Levels Following Heated Intraperitoneal Chemotherapy (HIPEC) Through Implementation of Standard Protocols. Ann Surg Oncol. 2023 11; 30(12):6981-6982.Ann Surg Oncol2023-08-25T00:00:002023Decreasing Environmental Operating Room Chemotherapy Levels Following Heated Intraperitoneal Chemotherapy (HIPEC) Through Implementation of Standard Protocols.Authorship 1082613937872456Bhutiani N, Grotz TE, Concors SJ, White MG, Helmink BA, Raghav KP, Taggart MW, Beaty KA, Royal RE, Overman MJ, Matamoros A, Scally CP, Rafeeq S, Mansfield PF, Fournier KFAnnals of surgical oncologyRepeat Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Appendiceal Adenocarcinoma: A Viable Treatment Strategy with Demonstrable Benefit. Ann Surg Oncol. 2024 Jan; 31(1):614-621.Ann Surg Oncol2023-10-23T00:00:002023Repeat Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Appendiceal Adenocarcinoma: A Viable Treatment Strategy with Demonstrable Benefit.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professor